These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27594187)

  • 21. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin pens for treatment of diabetes].
    Bärtsch U; Comtesse Ch; Wetekam B
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
    Ji J; Lou Q
    Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.
    Tandon N; Kalra S; Balhara YPS; Baruah MP; Chadha M; Chandalia HB; Prasanna Kumar KM; Madhu SV; Mithal A; Sahay R; Shukla R; Sundaram A; Unnikrishnan AG; Saboo B; Gupta V; Chowdhury S; Kesavadev J; Wangnoo SK
    Indian J Endocrinol Metab; 2017; 21(4):600-617. PubMed ID: 28670547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining Factors That Impact Inpatient Management of Diabetes and the Role of Insulin Pen Devices.
    Smallwood C; Lamarche D; Chevrier A
    Can J Diabetes; 2017 Feb; 41(1):102-107. PubMed ID: 27600025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.
    Lee LJ; Li Q; Reynolds MW; Pawaskar MD; Corrigan SM
    J Med Econ; 2011; 14(1):75-86. PubMed ID: 21231863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of protocol-guided scheduled basal-nutritional-correction insulin over standard care for vascular surgery patients.
    Harbin M; Dossa A; de Lemos J; Drummond I; Paty B; Taylor B
    Can J Diabetes; 2015 Jun; 39(3):210-5. PubMed ID: 25639852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New injection recommendations for patients with diabetes.
    Davidson JA
    Diabetes Metab; 2010 Sep; 36 Suppl 2():S2. PubMed ID: 20933207
    [No Abstract]   [Full Text] [Related]  

  • 33. U-500 insulin: why, when and how to use in clinical practice.
    Garg R; Johnston V; McNally PG; Davies MJ; Lawrence IG
    Diabetes Metab Res Rev; 2007 May; 23(4):265-8. PubMed ID: 17109474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transitioning and adjusting insulin analog therapy in elderly patients.
    Bray B
    Consult Pharm; 2008 Apr; 23 Suppl B():17-23. PubMed ID: 18540789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making the transition from oral to insulin therapy.
    Riddle MC
    Am J Med; 2005 May; 118 Suppl 5A():14S-20S. PubMed ID: 15850549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing barriers to insulin therapy: the role of insulin pens.
    Magwire ML
    Am J Ther; 2011 Sep; 18(5):392-402. PubMed ID: 20838202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considerations in insulin delivery device selection.
    Valentine V; Kruger DF
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S98-S100. PubMed ID: 20515315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.